48 reports

It is considered as an essential tool for the recognition of drugs, alcohol, asthma, tuberculosis, cancer, and other diseases.

  • Drug Test
  • Opioid
  • World
  • Forecast
  • Danaher Corporation

It is also developing new approaches to the treatment of asthma.

  • Opioid
  • Therapy
  • United States
  • Lightlake Therapeutics Inc.
  • Opiant Pharmaceuticals, Inc.
  • 4.3.1 LIMITATIONS OF INTRAVENOUS NSAIDS
  • 4.3 CHALLENGES

Physicians also avoid NSAIDs in surgeries that have no tolerance for bruising, patients with respiratory diseases such as asthma, nasal polyps and aspirin allergy.

  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.

Pain; ##: ##-##.

  • Opioid
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.
  • Salix Pharmaceuticals, Ltd.

Nitto Denko has been a provider of passive transdermal systems especially in the area of angina treatment and asthma treatment.

  • Opioid
  • Generex Biotechnology Corporation
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.

ANOTHER PROBLEM THAT HAS GREATLY CURTAILED THE USE OF IV NSAIDS IS PATIENTS WITH RESPIRATORY DISEASES (ASTHMA, NASAL POLYPS/ ASPIRIN ALLERGY) WHO ARE AT GREATER RISK.

  • Opioid
  • United States
  • Actavis plc
  • Bedrocan Canada Inc.
  • Medical Marijuana, Inc.

Drivers and their Impact Impact on End-user Category Driver Expiry of Patents Increased Investment in Healthcare Infrastructure Hospitals Low Low ## ## ## ## ## High Low Pharmaceutical Stores High ## ## ## ## ## High Low High ## ## ## ## ## ## ## ## ## ## Cost Factor Increase in Elde

  • Anti-Infective
  • Opioid
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation
  • Development Status
  • 6. PRODUCT PROFILES

APPROXIMATELY ## MILLION AMERICANS SUFFER FROM ASTHMA AND ##% OF TOTAL ASTHMA CASES IN THE US ARE OF " ALLERGIC-ASTHMA".

  • Opioid
  • North America
  • United States
  • Demand
  • Market Size
  • Napp Pharmaceuticals Ltd - Business Description
  • Company Overview

We are delighted to have been nominated for the HSJ' s Best Pharmaceutical Partnership with the NHS for not one, but two examples of our work in areas that are of great interest to the NHS: the treatment of asthma and the uptake of biosimilars.

  • Opioid
  • Pharmaceutical
  • United Kingdom
  • Company
  • Napp Pharmaceuticals Limited
  • Mundipharma International Ltd - SWOT Analysis SWOT Analysis - Overview
  • Section 2 - Company Analysis Company Overview

The respiratory therapeutics includes flutiform and flutiformo for asthma.

  • Opioid
  • Europe
  • United Kingdom
  • Company
  • Mundipharma International Corporation Limited

Effective January ##, 2017, Xtampza ER is one of three preferred brands on Cigna commercial formulary.

  • Opioid
  • United States
  • Company
  • Company Financials
  • Collegium Pharmaceutical, Inc.

## Infection ## Herpes Simplex Virus ## Infection ## Hormone Deficiency ## Hepatitis B Infection ## Stress ## Vitamin D Deficiency ## Enterovirus Infection ## Adenovirus Infection ## Heart Failure ## Anemia ## Cancer ## Hepatitis C Infection ## Thyroid Disease ## Von Willebrand Disease ## Varicella-zoster

  • Healthcare
  • Hormone
  • Immunochemistry Test
  • Opioid
  • Siemens Healthcare GmbH

About ## percent of asthma patients fail to take their medication as directed, and half of patients with asthma misuse their inhalers.

  • Healthcare
  • Opioid
  • Pharmaceutical
  • United States
  • Company Financials

It is also developing new approaches to the treatment of asthma.

  • Opioid
  • Pharmaceutical
  • United States
  • Company Financials
  • Orexo US Inc.

NO has a solid place in asthma management.

  • Drug Test
  • Opioid
  • United States
  • Alere Inc.
  • Dräger Group
  • 5. All the trials included are unique trials.

Patients were randomized to one of three treatment groups (##:##:##) and received either a single IA injection of ZILRETTA (## mg), normal saline-placebo or triamcinolone acetonide in crystalline suspension (TAcs) (## mg).

  • Arthritis
  • Clinical Trial
  • Musculoskeletal Disorder
  • Opioid
  • Pain Therapeutics
  • 5. All the trials included are unique trials.

## ## ## ## ## ## India ## ## ## ## ## ## Brazil ## ## ## ## ## ## Mexico ## ## ## ## ## ## Russia ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken

  • Clinical Trial
  • Opioid
  • Therapy
  • World
  • Product Initiative

About ## percent of asthma patients fail to take their medication as directed, and half of patients with asthma misuse their inhalers.

  • Healthcare
  • Opioid
  • Pharmaceutical
  • United States
  • Company Financials
  • DRUG OVERDOSE - PIPELINE BY ADAMIS PHARMACEUTICALS CORP, H2 2018
  • DRUG OVERDOSE - PIPELINE BY ADAPT PHARMA LTD, H2 2018

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/ CTA Filed, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ##, ##, ## and ## respectively.

  • Anesthetics
  • Opioid
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.

It is also developing new approaches to the treatment of asthma.

  • Healthcare
  • Opioid
  • Pharmaceutical
  • United States
  • Daiichi Sankyo Company

The company' s products include penthrox, asthma and COPD, medical devices and veterinary products.

  • Healthcare
  • Opioid
  • Pharmaceutical
  • United States
  • Purdue Pharma L.P.

Regeneron also has various product candidates under clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Chronic Pain
  • Opioid
  • United States
  • Product Initiative
  • Egalet Corporation
  • DRUG ADDICTION - PIPELINE BY KYORIN PHARMACEUTICAL CO LTD
  • DRUG ADDICTION - PIPELINE BY CHIESI FARMACEUTICI SPA

Brar participated in development efforts for asthma and topical Aristocort.

  • Antiseptics
  • Drug Test
  • Opioid
  • United States
  • Omeros Corporation
  • Clinical Trial profile. 161 Trial Title

The prominent features of this report are - ##.

  • Ophthalmic Solution
  • Opioid
  • OTC
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Opioid
  • Pharmaceutical
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Hormone
  • Neurology
  • Opioid

AYX-## ACTS BY TARGETING EARLY GROWTH RESPONSE GENE ## (EGR-##).

  • Opioid
  • United States
  • Company
  • Product Initiative
  • AcelRx Pharmaceuticals, Inc.

AYX-## acts by targeting early growth response gene ## (EGR-##).

  • Eye Disease
  • Opioid
  • Pharmaceutical
  • United States
  • AcelRx Pharmaceuticals, Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Opioid
  • World
  • Pfizer Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Drug Discovery And Development
  • Opioid
  • Pfizer Inc.